Candriam SCA’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.84M | Sell |
144,830
-29,690
| -17% | -$1.4M | 0.04% | 306 |
|
|
2025
Q1 | $6.82M | Sell |
174,520
-52,956
| -23% | -$2.07M | 0.04% | 280 |
|
|
2024
Q4 | $12.3M | Sell |
227,476
-11,524
| -5% | -$624K | 0.07% | 234 |
|
|
2024
Q3 | $12M | Hold |
239,000
| – | – | 0.07% | 246 |
|
|
2024
Q2 | $10.5M | Hold |
239,000
| – | – | 0.06% | 250 |
|
|
2024
Q1 | $12M | Buy |
239,000
+54,000
| +29% | +$2.71M | 0.08% | 236 |
|
|
2023
Q4 | $11.2M | Buy |
+185,000
| New | +$11.2M | 0.08% | 236 |
|